Dicerna Pharmaceuticals Inc: key financial figures for fiscal year 2020 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2020)
- $164.3M
- Net Income/Loss (FY2020)
- -$112.7M
- Total Assets (FY2020)
- $707.8M
- Total Equity (FY2020)
- $137.8M
- Cash Flows from Operating Activities (FY2020)
- $175.1M
Source: Dicerna Pharmaceuticals Inc 10-K filing (FY2020). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
